Australia markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
243.61+6.16 (+2.59%)
At close: 04:00PM EDT
245.00 +1.39 (+0.57%)
Pre-market: 04:09AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-21,153
-21,153
-44,881
-42,042
-57,203
Depreciation & amortisation
2,846
2,846
1,858
1,218
840
Stock-based compensation
82,470
82,470
51,970
26,178
12,817
Change in working capital
-40,781
-40,781
1,810
-6,855
-10,878
Accounts receivable
-30,218
-30,218
-27,017
-9,244
-11,842
Inventory
-21,999
-21,999
5,345
-8,752
-2,645
Accounts payable
9,296
9,296
14,355
4,779
2,048
Other working capital
1,024
1,024
2,473
-24,787
-55,500
Other non-cash items
3,740
3,740
816
1,368
1,401
Net cash provided by operating activities
24,653
24,653
11,569
-20,119
-53,045
Cash flows from investing activities
Investments in property, plant and equipment
-23,629
-23,629
-9,096
-4,668
-2,455
Purchases of investments
-281,439
-281,439
-10,500
-9,993
-52,721
Sales/maturities of investments
10,246
10,246
0
43,800
141,803
Net cash used for investing activities
-294,822
-294,822
-19,596
29,139
86,627
Cash flows from financing activities
Debt repayment
0
0
-24,500
0
-
Common stock issued
0
0
243,801
0
124,654
Other financing activities
-17,158
-17,158
-43
-
-
Net cash used provided by (used for) financing activities
13,950
13,950
235,077
14,948
134,065
Net change in cash
-256,055
-256,055
227,125
23,949
167,658
Cash at beginning of period
441,592
441,592
214,467
190,518
22,860
Cash at end of period
185,537
185,537
441,592
214,467
190,518
Free cash flow
Operating cash flow
24,653
24,653
11,569
-20,119
-53,045
Capital expenditure
-23,629
-23,629
-9,096
-4,668
-2,455
Free cash flow
1,024
1,024
2,473
-24,787
-55,500